We have located links that may give you full text access.
High frequency neuronal oscillatory abnormalities in the phospholipase C-β1 knockout mouse model of schizophrenia.
International Journal of Neuropsychopharmacology 2018 December 5
Background: Schizophrenia is a complex neuropsychiatric disorder characterised by psychoses, socioaffective disturbances and cognitive deficits. The phosphodiesterase enzyme phospholipase C-β1 (PLC-β1) has been reported to be reduced in post-mortem tissue of schizophrenia patients. Dysregulation of neuronal oscillations, particularly those in the higher frequency range, such as beta (12-30 Hz) and gamma (30-80 Hz), are also associated with this disorder. We investigated the influence of PLC-β1 gene deletion on cortical oscillatory activity and sensorimotor gating behavior.
Methods: Adult PLC-β1 knock-out (PLC-β1-/-) and wildtype C57Bl/6J control mice (total n=26) underwent surgical implantation of extradural electrodes to allow electrocorticography (ECoG) recordings. ECoG was recorded during prepulse inhibition (PPI) behavior sessions to measure ongoing and auditory-evoked electrophysiological responses. Mice were also pre-treated with antipsychotic drugs haloperidol (0.25mg/kg), clozapine (2.5mg/kg) and olanzapine (5mg/kg).
Results: PLC-β1-/- mice exhibited reduced PPI, and diminished power and phase synchrony of beta and gamma oscillatory responses to auditory stimuli, as well as elevated ongoing beta oscillations. Reductions in PPI were highly correlated with the power and phase synchrony of evoked oscillations. Clozapine and olanzapine ameliorated the PPI deficit in PLC-β1 -/- mice, but not the electrophysiology abnormalities.
Conclusions: PLC-β1 reduction leads to disturbances to beta and gamma oscillatory dynamics, and PPI behavior. The strong relationships between these measures demonstrate the importance of event-related oscillatory activity to sensorimotor gating behavior. However, dissociation of these measures observed in the drug studies suggests that abnormalities in neuronal networks may not necessarily need to be corrected for behavioral improvement.
Methods: Adult PLC-β1 knock-out (PLC-β1-/-) and wildtype C57Bl/6J control mice (total n=26) underwent surgical implantation of extradural electrodes to allow electrocorticography (ECoG) recordings. ECoG was recorded during prepulse inhibition (PPI) behavior sessions to measure ongoing and auditory-evoked electrophysiological responses. Mice were also pre-treated with antipsychotic drugs haloperidol (0.25mg/kg), clozapine (2.5mg/kg) and olanzapine (5mg/kg).
Results: PLC-β1-/- mice exhibited reduced PPI, and diminished power and phase synchrony of beta and gamma oscillatory responses to auditory stimuli, as well as elevated ongoing beta oscillations. Reductions in PPI were highly correlated with the power and phase synchrony of evoked oscillations. Clozapine and olanzapine ameliorated the PPI deficit in PLC-β1 -/- mice, but not the electrophysiology abnormalities.
Conclusions: PLC-β1 reduction leads to disturbances to beta and gamma oscillatory dynamics, and PPI behavior. The strong relationships between these measures demonstrate the importance of event-related oscillatory activity to sensorimotor gating behavior. However, dissociation of these measures observed in the drug studies suggests that abnormalities in neuronal networks may not necessarily need to be corrected for behavioral improvement.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app